logo
Plus   Neg
Share
Email

Zafgen To Explore Strategic Options After FDA Hold On ZGN-1061 - Quick Facts

Biopharmaceutical company Zafgen, Inc. (ZFGN) announced Thursday plans to explore strategic options to maximize shareholder value including but not limited to, an acquisition, merger, business combination, in-licensing, or other strategic transaction involving the Company or its assets.

A transaction committee has been formed within the Board of Directors for exploring potential strategic alternatives.

The company is taking this action based on the preliminary results from its ongoing nonclinical study to translate in vitro differentiation results into an in vivo model system. The company believes there is low probability of resolving the clinical hold in the near-term.

Based on preliminary results from this study reviewed this week, Zafgen does not presently expect the data to warrant resolution of the clinical hold for ZGN-1061, which is its investigational MetAP2 inhibitor in development.

In November 2018, the FDA has placed a clinical hold on the Investigational New Drug Application for the Company's first U.S. clinical trial of ZGN-1061 for the treatment of type 2 diabetes, citing the possibility of cardiovascular (CV) safety risk.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dunkin' Brands Group said it is rolling out the Beyond Sausage Sandwich to more than 9,000 restaurants nationwide, starting November 6. The sandwich features a plant-based sausage patty from alternative meat maker Beyond Meat. Beyond Meat's breakfast sausage patty is made with plant-based protein and a mix of spices crafted specifically for Dunkin'. Boeing said it understands and regrets the concern caused by the publications of instant messages involving a former test pilot that he "unknowingly" lied to regulators about a flight-control system on the Boeing 737 Max aircraft. The aircraft maker said it especially regrets the difficulties that the release of the messages presented for the U.S. Federal Aviation Administration or FAA. Boeing said Sunday that it had informed the Federal Aviation Administration and international regulators on multiple occasions about the expanded role of the flight-control software in 737 MAX, which was linked to two fatal crashes that killed 346 people.
RELATED NEWS
Follow RTT
>